These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 26299165)
1. Clinical value of natriuretic peptides in chronic kidney disease. Santos-Araújo C; Leite-Moreira A; Pestana M Nefrologia; 2015; 35(3):227-33. PubMed ID: 26299165 [TBL] [Abstract][Full Text] [Related]
2. Are natriuretic peptides useful biomarkers in dialysis patients? van den Kerkhof JJ; Van der Sande FM; Leunissen K; Kooman JP Perit Dial Int; 2007; 27(6):636-40. PubMed ID: 17984422 [No Abstract] [Full Text] [Related]
3. Clinical utility of natriuretic peptides in dialysis patients. Wang AY Semin Dial; 2012 May; 25(3):326-33. PubMed ID: 22607214 [TBL] [Abstract][Full Text] [Related]
4. Early markers of cardiovascular risk in chronic kidney disease. Lai S; Dimko M; Galani A; Coppola B; Innico G; Frassetti N; Mazzei ED; Mariotti A Ren Fail; 2015 Mar; 37(2):254-61. PubMed ID: 25394527 [TBL] [Abstract][Full Text] [Related]
5. Measuring risk in end-stage renal disease: is N-terminal pro brain natriuretic peptide a useful marker? Rosner MH Kidney Int; 2007 Mar; 71(6):481-3. PubMed ID: 17344896 [TBL] [Abstract][Full Text] [Related]
6. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults. Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of B-type natriuretic peptide for estimating left atrial size and its usefulness for predicting all-cause mortality and cardiovascular events among chronic haemodialysis patients. Ishigami J; Iimori S; Kuwahara M; Sasaki S; Tsukamoto Y Nephrology (Carlton); 2014 Dec; 19(12):777-83. PubMed ID: 25142830 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of B-type natriuretic peptide for assessment of left ventricular function in patients with chronic kidney disease. Soleimani A; Nasiri O; Nikoueinejad H; Mianehsaz E; Yousefzade M; Foroozanfard F; Tabatabaizadeh M; Moraveji SA; Rajali M Iran J Kidney Dis; 2011 Jul; 5(4):242-7. PubMed ID: 21725181 [TBL] [Abstract][Full Text] [Related]
15. Kidney function crucially affects B-type natriuretic peptide (BNP), N-terminal proBNP and their relationship. Takase H; Dohi Y Eur J Clin Invest; 2014; 44(3):303-8. PubMed ID: 24372567 [TBL] [Abstract][Full Text] [Related]
16. Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction. Odar-Cederlöf I; Bjellerup P; Williams A; Blagg CR; Twardowski Z; Ting G; Kjellstrand CM Hemodial Int; 2006 Oct; 10(4):394-8. PubMed ID: 17014518 [TBL] [Abstract][Full Text] [Related]
17. [Relationship between B-type natriuretic peptide plasma level and left ventricular function in patients with chronic kidney disease on different type of treatment]. Rasić S; Hadzovic-Dzuvo A; Rebić D; Dzemidzić J; Bilal F; Mataradzija A Acta Med Croatica; 2008; 62 Suppl 1():7-11. PubMed ID: 18578326 [TBL] [Abstract][Full Text] [Related]
18. [Brain natriuretic peptide (BNP) and N-terminal-pro BNP in chronic haemodialysed renal failure]. Bertinchant JP Arch Mal Coeur Vaiss; 2004 Sep; 97(9):881-8. PubMed ID: 15521481 [TBL] [Abstract][Full Text] [Related]